Craft

Advanced
Anokion

Anokion

Total Funding

$77.6 M

Anokion Summary

Company Summary

Overview
Anokion is an immune tolerance company focused on autoimmune disease treatment. Its immune tolerance platform features proteins or antigens engineered to deliver disease therapy.
Type
Private
Status
Active
Founded
2010
HQ
Ecublens, CH | view all locations
Website
https://anokion.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Jeffrey Hubbell, Co-founder, Chief Scientific Advisor, Director

    • Hilda M. Buehler

      Hilda M. Buehler, Senior Director, Controller

      • Mike Clayman, Chairman

        • Dhavalkumar Patel, Director

          Operating MetricsView all

          Phase II Trials Products

          1

          Jun, 2023

          Phase I Trials Products

          1

          Jun, 2023

          Preclinical Phase Products

          1

          Jun, 2023

          LocationsView all

          2 locations detected

          • Ecublens, VD HQ

            Switzerland

            Chemin de la Dent d'Oche 1 A

          • Cambridge, MA

            United States

            50 Hampshire St Suite 402, 4th floor

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX